Is DRMA overvalued right now?
A stock is overvalued when its market price sits above a reasonable fair value range. Use the live snapshot on this page for DRMA, then validate with fundamentals and peer multiples.
Dermata Therapeutics, Inc. (DRMA) valuation snapshot
Instant valuation answer
Dermata Therapeutics, Inc. (DRMA) valuation snapshot is loading. Our models compare market price to fair value using DCF, P/E, and P/S frameworks.
- Upside/Downside (live) — (from live valuation API)
- Confidence (live) — (—)
Confidence Score is based on the magnitude of upside or downside vs intrinsic value.
Fair value estimate
Unlock fair valueCurrent price
$1.41
Stock valuation checker
Search our company database (same as the site header). Choose a result or type a ticker and press Check valuation.
Explore Our Valuation Calculators
Why is Dermata Therapeutics, Inc. overvalued or undervalued?
Intrinsic value work anchors Dermata Therapeutics, Inc. on owner earnings and balance-sheet capacity; the current quote trades below that anchor, which frames the stock as relatively cheap on a fundamentals-first view.
Versus historical valuation bands, DRMA is closer to the lower end of where this business has traded when profitability and growth were comparable—useful context before reading any single headline multiple.
Forward market expectations are muted: the price does not require heroic assumptions to converge with our fair-value zone, but sector peers and macro rates still deserve a quick sanity check on the company page.
Key metrics
- P/E ratio
- 30.5x
- Revenue growth (TTM y/y)
- 9%
- Profit margin
- 23.1%
- Fair value (model)
- Unlock
Frequently asked questions — DRMA
What is Dermata Therapeutics, Inc.'s intrinsic value?
Intrinsic value is an estimate of what DRMA shares may be worth based on fundamentals rather than today's price alone. See the valuation snapshot on this page for the latest model output.
How is Dermata Therapeutics, Inc.'s intrinsic value calculated?
Tickerplace calculates DRMA's fair value using Discounted Cash Flow (DCF), P/E Multiple, and P/S Multiple models. We compare the resulting intrinsic value estimate to the live market price to flag undervalued or overvalued positioning.
Is DRMA undervalued right now?
A stock is undervalued when price sits below a supportable fair value range. Check whether DRMA's gap aligns with fundamentals using the ratios and financial links on this page.
Related companies — valuation
Peers for DRMA: open their overvalued / undervalued view.